Replimune aims to raise $125M; Otsuka makes another deal with Ionis

Plus, news about Kanglin Biotechnology, Seelos, Orbus and Sonata: Replimune’s $125M offering: The biotech announced the offering four days after it submitted an FDA application for RP1 ...